FI68820C - Foerfarande foer framstaellning av terapeutiskt anvaendbara amnotiazoler - Google Patents

Foerfarande foer framstaellning av terapeutiskt anvaendbara amnotiazoler Download PDF

Info

Publication number
FI68820C
FI68820C FI791754A FI791754A FI68820C FI 68820 C FI68820 C FI 68820C FI 791754 A FI791754 A FI 791754A FI 791754 A FI791754 A FI 791754A FI 68820 C FI68820 C FI 68820C
Authority
FI
Finland
Prior art keywords
phenyl
hydrogen
compounds
monosubstituted
mol
Prior art date
Application number
FI791754A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI791754A7 (fi
FI68820B (fi
Inventor
Joseph George Lombardino
Jasjit Singh Bindra
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of FI791754A7 publication Critical patent/FI791754A7/fi
Publication of FI68820B publication Critical patent/FI68820B/fi
Application granted granted Critical
Publication of FI68820C publication Critical patent/FI68820C/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/38—Nitrogen atoms
    • C07D277/42—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/20—Radicals substituted by singly bound hetero atoms other than halogen by nitrogen atoms
    • F—MECHANICAL ENGINEERING; LIGHTING; HEATING; WEAPONS; BLASTING
    • F16—ENGINEERING ELEMENTS AND UNITS; GENERAL MEASURES FOR PRODUCING AND MAINTAINING EFFECTIVE FUNCTIONING OF MACHINES OR INSTALLATIONS; THERMAL INSULATION IN GENERAL
    • F16B—DEVICES FOR FASTENING OR SECURING CONSTRUCTIONAL ELEMENTS OR MACHINE PARTS TOGETHER, e.g. NAILS, BOLTS, CIRCLIPS, CLAMPS, CLIPS OR WEDGES; JOINTS OR JOINTING
    • F16B15/00—Nails; Staples
    • F16B15/0023—Nail plates
    • F16B2015/0076—Nail plates with provisions for additional fastening means, e.g. hooks, holes for separate screws or nails, adhesive

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
FI791754A 1978-06-02 1979-06-01 Foerfarande foer framstaellning av terapeutiskt anvaendbara amnotiazoler FI68820C (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US91183078A 1978-06-02 1978-06-02
US91183078 1978-06-02

Publications (3)

Publication Number Publication Date
FI791754A7 FI791754A7 (fi) 1979-11-26
FI68820B FI68820B (fi) 1985-07-31
FI68820C true FI68820C (fi) 1985-11-11

Family

ID=25430923

Family Applications (1)

Application Number Title Priority Date Filing Date
FI791754A FI68820C (fi) 1978-06-02 1979-06-01 Foerfarande foer framstaellning av terapeutiskt anvaendbara amnotiazoler

Country Status (36)

Country Link
JP (1) JPS5936988B2 (cs)
AR (1) AR226285A1 (cs)
AT (1) AT373248B (cs)
AU (1) AU511242B2 (cs)
BE (1) BE876732A (cs)
CA (1) CA1117949A (cs)
CH (1) CH639653A5 (cs)
CS (1) CS216927B2 (cs)
DD (1) DD144055A5 (cs)
DE (1) DE2922523C2 (cs)
DK (1) DK150068C (cs)
EG (1) EG14354A (cs)
ES (1) ES481220A1 (cs)
FI (1) FI68820C (cs)
FR (1) FR2427333A1 (cs)
GB (1) GB2022085B (cs)
GR (1) GR73142B (cs)
HK (1) HK66487A (cs)
HU (1) HU180045B (cs)
IE (1) IE48426B1 (cs)
IL (1) IL57450A (cs)
IT (1) IT1121238B (cs)
KE (1) KE3459A (cs)
LU (1) LU81349A1 (cs)
MY (1) MY8500318A (cs)
NL (1) NL178421C (cs)
NO (1) NO150760C (cs)
NZ (1) NZ190623A (cs)
PH (1) PH17020A (cs)
PL (1) PL117515B1 (cs)
PT (1) PT69718A (cs)
SE (1) SE438333B (cs)
SG (1) SG56184G (cs)
SU (1) SU843746A3 (cs)
YU (1) YU40997B (cs)
ZA (1) ZA792729B (cs)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS57501565A (cs) * 1980-10-24 1982-09-02
JPS57136579A (en) * 1981-01-21 1982-08-23 Mitsui Toatsu Chem Inc Thiazolylurea derivative, its preparation, and pharmaceutical composition containing the same
DE3264595D1 (en) * 1981-01-08 1985-08-14 Mitsui Toatsu Chemicals N-(4-phenyl-2-thiazolyl)carbamate derivatives, process for their preparation, and medicinal composition containing same
JPS57116067A (en) * 1981-01-12 1982-07-19 Sankyo Kagaku Kk Novel 8-quinolinesulfonyl derivative, its synthesis and use
WO1982002386A1 (en) * 1981-01-13 1982-07-22 Sakano Isao Aminothiazole derivatives,process for their preparation,and medicinal composition containing same
US4501750A (en) * 1981-01-13 1985-02-26 Mitsui Toatsu Kaguku Kabushiki Kaisha Thiazole compounds, a process for preparing same and a pharmaceutical composition containing the thiazole compounds
JPS57154175A (en) * 1981-03-16 1982-09-22 Mitsui Toatsu Chem Inc 2-thiazoleamine derivative, its preparation, and drug composition comprising it
DE3227329A1 (de) * 1982-07-22 1984-01-26 Basf Ag, 6700 Ludwigshafen Verfahren zur herstellung von 2-n,n-disubstituierten aminothiazolen
WO1986003203A1 (fr) * 1984-11-22 1986-06-05 Yoshitomi Pharmaceutical Industries, Ltd. Derives de thienylthiazole
FR2581063B1 (fr) * 1985-04-30 1987-07-17 Chauvin Blache Lab Amino-2 thiazoles n-substitues, leur procede de preparation et leur application en therapeutique
JPS63152368A (ja) * 1986-06-03 1988-06-24 Sumitomo Pharmaceut Co Ltd 新規なアミノアゾ−ル誘導体およびその酸付加塩
JPH075579B2 (ja) * 1986-09-01 1995-01-25 吉富製薬株式会社 アミノチアゾ−ル化合物
JPH0753666B2 (ja) * 1987-09-14 1995-06-07 久光製薬株式会社 置換ジフェニルチアゾール誘導体からなる抗炎症剤
CA2065399C (en) * 1989-08-09 2001-07-31 Stephen George Szirmai Producing electrosuspensions
WO1992015570A1 (fr) * 1991-03-07 1992-09-17 Hisamitsu Pharmaceutical Co., Inc. Nouveau derive de diphenylthiazole
FR2692893B1 (fr) * 1992-06-24 1994-09-02 Sanofi Elf Dérivés alkylamino ramifiés du thiazole, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent.
JPH10504542A (ja) * 1994-07-27 1998-05-06 ジー．ディー．サール アンド カンパニー 炎症処置用の置換チアゾール化合物
FR2754258B1 (fr) 1996-10-08 1998-12-31 Sanofi Sa Derives d'aminothiazole, leur procede de preparation et les compositions pharmaceutiques les contenant
AU2001237401B2 (en) * 2000-03-01 2006-11-09 Janssen Pharmaceutica N.V. 2,4-disubstituted thiazolyl derivatives
WO2003015777A1 (en) * 2001-08-13 2003-02-27 Lion Bioscience Ag Nr1h4 nuclear receptor binding compounds
EP1432698A2 (en) * 2001-09-26 2004-06-30 Bayer Pharmaceuticals Corporation Substituted 3-pyridyl indoles and indazoles as c17,20 lyase inhibitors
DE60328161D1 (de) 2002-01-11 2009-08-13 Daiichi Sankyo Co Ltd Aminoalkoholderivat oder phosphonsäurederivat und diese enthaltende medizinische zusammensetzung
EP1555264A1 (en) * 2004-01-15 2005-07-20 Sireen AG Five-membered heterocyclic compounds as inhibitors of SRC family protein kinase.
NZ549162A (en) 2004-02-24 2009-12-24 Sankyo Co Amino-pyrrol alcohol compounds
EP1879575A2 (en) * 2005-05-09 2008-01-23 Achillion Pharmaceuticals, Inc. Thiazole compounds and methods of use
KR20080091369A (ko) 2006-01-18 2008-10-10 암젠 인크 단백질 키나제 ｂ （ｐｋｂ） 억제제로서 티아졸 화합물
US7897619B2 (en) 2007-07-17 2011-03-01 Amgen Inc. Heterocyclic modulators of PKB
US7919504B2 (en) 2007-07-17 2011-04-05 Amgen Inc. Thiadiazole modulators of PKB
WO2012170951A2 (en) * 2011-06-10 2012-12-13 Calcimedica, Inc. Compounds that modulate intracellular calcium
US20120316182A1 (en) 2011-06-10 2012-12-13 Calcimedica, Inc. Compounds that modulate intracellular calcium
US9856240B2 (en) 2011-10-19 2018-01-02 Calcimedica, Inc. Compounds that modulate intracellular calcium
CN110590785B (zh) * 2019-09-23 2021-02-02 武汉大学 一种氨基噻唑类化合物及其制备方法与抗肠道病毒71型的应用

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3458526A (en) * 1966-09-26 1969-07-29 Upjohn Co Certain 2-amino-4,5-bis(p-methoxyphenyl)thiazoles

Also Published As

Publication number Publication date
PH17020A (en) 1984-05-11
JPS54160369A (en) 1979-12-19
HU180045B (en) 1983-01-28
GB2022085A (en) 1979-12-12
PL216030A1 (cs) 1980-03-10
GR73142B (cs) 1984-02-09
DE2922523A1 (de) 1979-12-06
AU511242B2 (en) 1980-08-07
DE2922523C2 (de) 1982-10-21
FI791754A7 (fi) 1979-11-26
FI68820B (fi) 1985-07-31
MY8500318A (en) 1985-12-31
CS216927B2 (en) 1982-12-31
LU81349A1 (fr) 1979-12-07
ZA792729B (en) 1981-03-25
KE3459A (en) 1984-10-12
ES481220A1 (es) 1980-09-01
IL57450A (en) 1982-11-30
HK66487A (en) 1987-09-25
PL117515B1 (en) 1981-08-31
PT69718A (en) 1979-07-01
IT1121238B (it) 1986-03-26
YU128879A (en) 1982-10-31
IE791069L (en) 1979-12-02
FR2427333B1 (cs) 1983-05-20
ATA401679A (de) 1983-05-15
CH639653A5 (fr) 1983-11-30
IT7923228A0 (it) 1979-06-01
NO150760C (no) 1984-12-12
SE438333B (sv) 1985-04-15
GB2022085B (en) 1983-01-12
EG14354A (en) 1984-06-30
NL7904337A (nl) 1979-12-04
JPS5936988B2 (ja) 1984-09-06
IE48426B1 (en) 1985-01-23
DK177679A (da) 1979-12-03
NL178421C (nl) 1986-03-17
BE876732A (fr) 1979-12-03
NO791831L (no) 1979-12-04
SE7904798L (sv) 1979-12-03
DK150068B (da) 1986-12-01
SG56184G (en) 1985-03-08
SU843746A3 (ru) 1981-06-30
NZ190623A (en) 1984-07-06
AU4763479A (en) 1979-12-06
YU40997B (en) 1986-10-31
DD144055A5 (de) 1980-09-24
FR2427333A1 (fr) 1979-12-28
AT373248B (de) 1983-12-27
NL178421B (nl) 1985-10-16
IL57450A0 (en) 1979-09-30
AR226285A1 (es) 1982-06-30
CA1117949A (en) 1982-02-09
NO150760B (no) 1984-09-03
DK150068C (da) 1987-06-29

Similar Documents

Publication Publication Date Title
FI68820C (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara amnotiazoler
US4390701A (en) 1-Amino-2-[3-(3-piperidinomethylphenoxy)propylamino]cyclobutene-3,4-dione
EP0138464A2 (en) 2-Amino-5-hydroxy-4-methylpyrimidine derivatives
EP0066459B1 (en) Crystalline benzothiazine dioxide salts
HU179170B (en) Process for producing phenethanolamine derivatives
CA1067501A (en) Process for preparing substituted guanidines
EP0470006B1 (en) Thiourea derivatives and antimicrobial agent and antiulcer agent containing the same
US4307106A (en) Aminothiazoles
RU2056416C1 (ru) Производные тиомочевины, фармацевтическая композиция и способ лечения
HU181408B (en) Process for preparing substituted furan derivatives
US4526973A (en) Chemical compounds
US4395553A (en) Chemical compounds
HU182645B (en) Process for preparing n-cyano-n'-2-//4-methyl-5-imidazolyl/-methyl-thio/-ethyl-n''-alkinyl-guanidine
EP0105458B1 (en) Alpha-aryl-alpha-pyridylalkanoic acid derivatives, process for preparation thereof and pharmaceutical composition comprising the same
EP0189307A2 (en) Antihistamine-H2 alkyne thiadiazole derivatives
CS228929B2 (cs) Způsob výroby ve vodě rozpustných solí N-(2-pyridyl)-2-methyl-4-hydroxy-2H-l,2-benzothiazin-3-karboxamid-l,l-dioxidu
US4539316A (en) Pyridine derivatives of 1,2-diaminocyclobutene-3,4-diones
JPS6410512B2 (cs)
US4546188A (en) Substituted 1,2-diaminocyclobutene-3,4-diones
US4607105A (en) 3-cyclobutene-1,2-dione intermediates
US4788184A (en) Substituted 3-cyclobutene-1,2-diones as anti-ulcer agents
US4772704A (en) 2,5-disubstituted-4(3H)-pyrimidones having histamine H2 -receptor antagonist activity
KR820000848B1 (ko) 아미노 티아졸류의 제조방법
CH634075A5 (en) Process for the preparation of hydrated imidazothiazole and thiazolopyrimidine derivatives having an anti-inflammatory activity
KR820001303B1 (ko) 펜에탄올아민의 제조방법

Legal Events

Date Code Title Description
FG Patent granted

Owner name: KARHU-TITAN OY

MM Patent lapsed
BB Publication of examined application
MM Patent lapsed

Owner name: PFIZER INC.